Hepatitis C in Developing Countries

Produk Detail:
  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Pages : 278 pages
  • ISBN : 0128032340
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Hepatitis C in Developing Countries

Download or Read online Hepatitis C in Developing Countries full in PDF, ePub and kindle. this book written by Sanaa M. Kamal and published by Academic Press which was released on 23 November 2017 with total page 278 pages. We cannot guarantee that Hepatitis C in Developing Countries book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1. Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6 Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C

Hepatitis C in Developing Countries

Hepatitis C in Developing Countries
  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Release : 23 November 2017
GET THIS BOOK Hepatitis C in Developing Countries

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health

HCV and Related Liver Diseases

HCV and Related Liver Diseases
  • Author : Kiwamu Okita
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOK HCV and Related Liver Diseases

More than 2 million people in Japan have chronic hepatitis C and many of them will lose their lives to liver cirrhosis or complications of hepatocellular carcinoma. Hepatitis C virus-related diseases are a serious concern both in developing countries and in Japan and the United States, where the number of patients is also in the millions. Therapeutic modalities recently developed in Japan, including interferon therapy and nutritional supportive therapy, are gaining worldwide acceptance. At this critical juncture, HCV and Related Liver

Hepatitis C Virus NS3 NS5A and NS5B Proteins as Drug Targets

Hepatitis C Virus NS3  NS5A and NS5B Proteins as Drug Targets
  • Author : Mazhar Iqbal,Moazur Rahman,Anwar Muhammad Ikram,Muhammad Ikram Anwar
  • Publisher : LAP Lambert Academic Publishing
  • Release : 12 November 2014
GET THIS BOOK Hepatitis C Virus NS3 NS5A and NS5B Proteins as Drug Targets

Hepatitis C virus (HCV) infects 3% of world population with significant mortalities in developing countries. If HCV disease goes untreated, it can lead to cirrhosis, hepatocellular carcinoma and ultimately death of the patient. Currently in Pakistan, about 5 to 10% of population is infected with HCV. This book provides useful informations about diagnostic, prevalence and drug discovery initiative against HCV genotype-3a (HCV-3a), the most prevalent genotype in developing world, particularly in South Asia including Pakistan. Drug discovery imitative is pursued by

Advanced Therapy for Hepatitis C

Advanced Therapy for Hepatitis C
  • Author : Geoffrey W. McCaughan,John McHutchison,Jean-Michel Pawlotsky
  • Publisher : John Wiley & Sons
  • Release : 05 October 2011
GET THIS BOOK Advanced Therapy for Hepatitis C

According to the WHO, 170 million people, or 3% of the world's population, are infected with Hepatitis C and at risk of developing liver cirrhosis and/or liver cancer. 3-4 million people each year are newly diagnosed carriers of the virus. Advanced Therapy for Hepatitis C Infection provides you with expert guidance from the world’s leading hepatologists on the very latest treatment options for patients with the HCV virus. Focusing mainly on the efficacy and clinical use of antiviral therapies, key

Contemporary Obstetrics and Gynecology for Developing Countries

Contemporary Obstetrics and Gynecology for Developing Countries
  • Author : Friday Okonofua,Joseph A. Balogun,Kunle Odunsi,Victor N. Chilaka
  • Publisher : Springer Nature
  • Release : 05 August 2021
GET THIS BOOK Contemporary Obstetrics and Gynecology for Developing Countries

This book is a comprehensive and easy-to-read guide to obstetrics and gynecology in developing countries. Although significant progress has been made towards the reduction of maternal mortality and morbidity globally, they are still unacceptably high in developing countries. This can be directly or indirectly tied to poor quality maternal health care and lack of access to cost-effective, comprehensive healthcare. Health practitioners in developing countries also contend with trying to keep abreast of recent developments in obstetrics and gynecology while dealing

Recommendations and guidance on hepatitis C virus self testing

Recommendations and guidance on hepatitis C virus self testing
  • Author : World Health Organization
  • Publisher : World Health Organization
  • Release : 15 July 2021
GET THIS BOOK Recommendations and guidance on hepatitis C virus self testing

WHO has set a global goal to eliminate HCV as a public health problem by 2030. WHO estimates that 58 million people had chronic hepatitis C virus (HCV) infection globally in 2019, and less than a quarter of them were diagnosed. New and innovative approaches are needed to accelerate progress toward the HCV elimination targets. Self-testing is one such approach. These guidelines provide a new recommendation and guidance on HCV self-testing to complement existing HCV testing services in countries. These guidelines also highlight

Hepatitis C Virus The Next Epidemic An issue of Gastroenterology Clinics of North America

Hepatitis C Virus  The Next Epidemic  An issue of Gastroenterology Clinics of North America
  • Author : K. Rajender Reddy
  • Publisher : Elsevier Health Sciences
  • Release : 07 January 2016
GET THIS BOOK Hepatitis C Virus The Next Epidemic An issue of Gastroenterology Clinics of North America

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver

Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
  • Author : Steven K.H. Foung,Thomas F. Baumert
  • Publisher : Frontiers Media SA
  • Release : 22 January 2019
GET THIS BOOK Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research

Handbook of Hepatitis C

Handbook of Hepatitis C
  • Author : Nicolas Goossens,Sophie Clément,Francesco Negro
  • Publisher : Springer
  • Release : 25 May 2016
GET THIS BOOK Handbook of Hepatitis C

This book is a concise and up-to-date review of the clinical features, pathophysiology, diagnosis, and treatment of patients with hepatitis C. Busy health care professionals who want a quick review of hepatitis C and new developments in treatment for hepatitis C will benefit from this succinct guide. Hepatitis C virus primarily infects liver cells and can lead to chronic damage to the liver. Patients with hepatitis C infection often develop liver sequelae such as fibrosis, cirrhosis, and hepatocellular carcinoma if

A National Strategy for the Elimination of Hepatitis B and C

A National Strategy for the Elimination of Hepatitis B and C
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Population Health and Public Health Practice,Committee on a National Strategy for the Elimination of Hepatitis B and C
  • Publisher : National Academies Press
  • Release : 30 June 2017
GET THIS BOOK A National Strategy for the Elimination of Hepatitis B and C

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to

Kidney Diseases in the Developing World and Ethnic Minorities

Kidney Diseases in the Developing World and Ethnic Minorities
  • Author : Meguid El Nahas,Rashad Barsoum,John H. Dirks,Giuseppe Remuzzi
  • Publisher : CRC Press
  • Release : 29 August 2005
GET THIS BOOK Kidney Diseases in the Developing World and Ethnic Minorities

Compiled by an international team of nephrologists, this reference covers a wide variety of clinical, regional, and research issues related to the epidemiology, diagnosis, and treatment of kidney disease in ethnic populations-exploring current prevention strategies, treatment outcomes, and education and training practices in Africa, South America,

Hepatitis C

Hepatitis C
  • Author : Anonim
  • Publisher : Elsevier
  • Release : 09 October 2000
GET THIS BOOK Hepatitis C

The anticipated encore volume of the Biomedical Research Reports Series, Hepatitis C is the first book that offers comprehensive and up-to-date coverage of this "silent epidemic." The subject matter ranges from basic science to clinical medicine, with contributions from more than 30 international experts in the field. This important new book details the hepatitis C virus and the disease that it causes, including its prevalence, means of spread, symptoms, complications, natural history, prevention, and therapy. The editors, T. Jake Liang, M.

Hepatitis C Virus New Insights for the Healthcare Professional 2013 Edition

Hepatitis C Virus  New Insights for the Healthcare Professional  2013 Edition
  • Author : Anonim
  • Publisher : ScholarlyEditions
  • Release : 22 July 2013
GET THIS BOOK Hepatitis C Virus New Insights for the Healthcare Professional 2013 Edition

Hepatitis C Virus: New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Diagnosis and Screening. The editors have built Hepatitis C Virus: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Diagnosis and Screening in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of